DISCLOSURE OF CONFLICTS OF INTEREST
body with extending primary processes and secondary foot processes (1, 2) . These foot processes interdigitate to form uniquely specialized cell-cell contacts called slit diaphragms. The unique morphology of podocyte structure is dependent on the spatial and temporal regulation of the actin cytoskeleton which, if impaired, can cause proteinuric kidney diseases (3) (4) (5) .
FSGS is etiologically and genetically heterogeneous (6) . Highly penetrant Mendelian forms of FSGS are rare examples where we can unequivocally say we know the cause of disease (7) . Although rare in absolute terms, INF2-associated FSGS is among the most common forms of inherited FSGS (8) (9) (10) . Missense mutations in INF2 lead to kidney disease characterized by proteinuria, progressive kidney dysfunction, and FSGS with or without Charcot-Marie-Tooth disease (CMT) (11, 12) . Approximately 9 to 17 percent of familial FSGS patients have INF2 mutations (7) .
INF2 is one of the 15 members of formin family of proteins, which share a formin homology domain (FH2) involved in control of actin polymerization (13, 14) . However, most formins, including INF2, contain additional distinct regions of homology outside of the FH2 domain that are critical for actin assembly and interactions with regulatory binding partners. These regions include the diaphanous autoregulatory domain (DAD) near the INF2 C-terminus and the diaphanous inhibitory domain (DID)
near the INF2 N-terminus. An intermolecular interaction between the DID and DAD maintains INF2 in an autoinhibited state (15) . All pathogenic FSGS mutations of INF2 identified to date localize to the DID (16) Cells express at least two isoforms of INF2, CAAX and non-CAAX (17, 18) . The CAAX isoform localizes to ER-rich regions, whereas the non-CAAX form is cytoplasmic. Over the past few years, multiple studies have increased our understanding of INF2 isoform-mediated regulation of the actin cytoskeleton (15, (19) (20) (21) (22) (23) . Many of these studies have relied on the cooperative regulation of the INF2 DID-DAD interaction to explain INF2 activity, as exemplified by INF2 regulation of mitochondrial fission (23) (24) (25) . INF2 also modulates activity of other formins such as the mDIA subfamily, and promotes stable microtubule assembly (19, 26, 27) . While disease-associated INF2 mutations appear to alter the DID-DAD interaction, disruption of this interaction does not explain why such mutations are limited to the DID. We reasoned that the DID region of INF2 might have unique functions in glomeruli independent of the DAD.
In the present study, we report the existence of proteolytic cleavage of INF2 that causes the DID to localize and function independently of the DAD and FH2 regions. Furthermore, the ability of wild-type INF2, but not mutant R218Q, to counteract mDIA activity and promote cell spreading in a cleavagedependent manner indicates that INF2 possesses unique cleavage-dependent functions mediated via the N-terminal fragment. These activities are lost in the presence of pathogenic INF2 mutations.
RESULTS

INF2 is cleaved into two fragments separating the DID and DAD domains.
We reasoned that if the INF2 DID possesses unique functions, these might be mediated via additional splice variants of INF2 that span just the N-terminus, as the annotated human genome (visualized using Ensembl or the UCSC Genome Browser) suggests the existence of such transcripts (28, 29) .
To examine this experimentally, we looked for the splice isoforms of INF2 present in human podocytes. mRNA expression analysis showed that both an INF2-CAAX isoform and a short isoform However, using an antibody directed against the INF2 N-terminus, we observed an additional band of ~60 kDa in human glomerular lysates (Supplementary Figure 1E and Figure 1A ). Using an antibody directed against the INF2 C-terminus, we also observed an additional band of approximately 100 kDa size ( Figure 1A ). Neither of these bands were present in INF2 CRISPR KO podocytes ( Figure 1A ).
We saw similar INF2 immunoblot patterns in lysates from human glomeruli and primary human podocytes, as well as in glomeruli from wild-type mice, but not INF2 knockout mice ( Figure 1A and B).
When we overexpressed the INF2-CAAX isoform as GFP-INF2 or GFP-INF2-FLAG and probed for GFP or FLAG by immunoblot, we saw similar patterns ( Figure 1C ). Together, this data suggested specific cleavage in INF2 into two fragments, with the C-terminal fragment migrating at ~100 kDa and the N-terminal fragment migrating at ~60 kDa (~ 87kDa as the GFP-fusion) ( Figure 1C ).
To map the cleavage site, we overexpressed GFP-INF2-FLAG and immunoprecipitated the C-terminal fragment using an antibody to the FLAG tag, followed by N-terminal sequencing. The first five amino acids identified were "S-A-W-V-P" ( Figure 1D ). This sequence matched a unique locus on the Cterminal side of the INF2 DID ( Figure 1E ) and aligned with an in silico-predicted cathepsin K cleavage site spanning residues from 543-548. Cleavage was predicted to occur between INF2 residues glycine (G) 547 and serine (S) 548. To verify this cleavage site, we overexpressed a mutated form of GFP-INF2-FLAG in which we deleted the predicted cathepsin K cleavage site (non-cleavable GFP-INF2-FLAG). Cleavage fragments using this construct were no longer detectable by immunoblot ( Figure 1F ). This observation, along with the N-terminal sequencing results, confirmed that INF2
cleavage occurs between residues Glycine 547 and Serine 548.
INF2 localization in glomeruli from normal and diseased kidney tissues correlates with proteolytic
cleavage.
To examine whether INF2 cleavage has an in vivo human correlation, we used structured illumination microscopy (SIM) to determine INF2 distribution within glomeruli in kidney biopsy samples from individuals without known kidney disease, as well as from individuals with INF2-mediated FSGS (Figure 2 ), Alport syndrome, and systemic lupus erythematosus (lupus nephritis) (Supplementary Figure 3) . We stained these samples with both N-terminal-specific and C-terminal-specific INF2
antibodies to compare cleavage fragment localizations.
Consistent with our previous observations in mice (30) and as shown in Supplementary Figure 3 
INF2 N-fragment restores impaired cell spreading by antagonizing mDIA signaling.
We next evaluated whether the cleavage-induced differential localization of the two proteolytic fragments of INF2 regulates any specific cell functions, and if INF2 N-terminal fragment function might be altered in the presence of INF2 mutations. Our previous studies have shown that both the mutant podocytes from R218Q knock-in mice and siRNA-silenced INF2 human podocytes exhibit impaired cell spreading (26, 30) . These studies suggest that INF2 has a role in cell spreading that is altered in the presence of disease-causing mutations. We hypothesized that the cleaved N-fragment may normally help mediate the cell spreading function of INF2 and help maintain (or restore) normal podocyte structure.
To examine this, we first tested whether mouse INF2 KO podocytes and human INF2 CRISPR KO podocytes recapitulate the impaired cell spreading previously noted in other systems ( Figure 5A ).
Consistent with previous observation, we found that both mouse INF2 KO podocytes and human INF2
CRISPR KO podocytes exhibited impaired cell spreading compared to their respective controls ( Figure 5A ). We next tested whether presence of the INF2 N-fragment restores normal cell spreading.
As depicted in Figure 5B , we transfected mouse INF2 KO podocytes with different GFP-INF2
constructs to achieve equivalent expression levels and evaluated possible restoration of cell spreading. We found that expressing wild-type N-fragment in INF2 KO podocytes restored normal cell spreading in the INF2 KO cells. Normal cell spreading was partially restored by expression of the wild-type full-length INF2, but not by the non-cleavable form of full-length INF2. In contrast, none of the R218Q-mutant constructs produced any recovery in cell spreading. Similar effects on cell spreading were noted in human INF2 CRISPR KO podocytes transiently overexpressing wild-type INF2 N-fragment but not in podocytes overexpressing the R218Q mutant N-fragment ( Figure 5C ).
Our earlier studies showed that impaired podocyte cell spreading in the presence of INF2 mutations was associated with aberrantly increased mDIA signaling (26, 30) , which we attributed to loss of an inhibitory interaction between INF2-DID and mDIA-DAD (19) . Therefore, we examined whether the cleaved INF2 N-fragments interacted with mDIA in order to correlate our cleavage-dependent cell spreading observations with earlier findings suggesting a specific INF2-mDIA interaction {REFSXXX}.
We observed that that wild-type INF2 N-fragment interacted with mDIA, and that this interaction was significantly reduced in the presence of R218Q mutant INF2. We observed a similar trend using fulllength wild-type and R218Q mutant INF2 ( Figure 5D ). More importantly, the non-cleavable form of INF2 (both wild-type and R28Q mutant) did not interact with mDIA. These results indicate that INF2
cleavage mediates the antagonistic effect of INF2 DID on mDIA and that the INF2 N-fragment specifically promotes cell spreading. In the presence of an FSGS-associated INF2 point mutation, the ability of the N-terminal fragment to promote cell spreading is lost.
DISCUSSION
Multiple studies have indicated that INF2, through its effects on actin and microtubules, can modulate mitochondrial fission, calcium uptake, vesicle trafficking, T-cell polarization, and placental implantation, among numerous other cell processes (23, 24, (31) (32) (33) (34) . The mechanisms by which FSGS-associated (and Charcot-Marie-Tooth associated) mutations cause disease is not well understood. In particular, explanations remain unclear for the restricted localization of these mutations to the INF2 N-terminal region, possible manifestations of differential evolutionary pressures experienced by the N and C terminal portions of INF2 gene products (8, 9, 16) .
In this study, we have demonstrated that INF2 undergoes a proteolytic program that can cause the DID in the N-terminal region of INF2 to function independently of the DAD in the INF2 C-terminal region ( Figure 6 ). As all the human INF2 mutations identified to date have been confined to the DIDcontaining N-terminus, this observation suggests that N-fragment dependent functions must be integral for glomerular structure and function, and provides a potential clue to why all mutations are limited to the DID region. In addition, we observed that INF2-induced cell spreading and the interaction of mDIA with INF2 are cleavage-dependent properties and are both significantly reduced in the presence of a disease mutation. These results are consistent with our earlier findings on INF2 and mDIA-related cell spreading effects (26, 30 Nevertheless, the results presented here point to a specific role for the N-terminal region in podocyte foot processes. This activity may be lost in FSGS caused by N-terminal INF2 mutations.
All FSGS-associated mutations (with or without associated CMT) localize to the INF2 N-terminal region (37) . This suggests that the N-terminal region is important for the integrity of the foot process and slit diaphragm structures, and suggests that INF2 cleavage has in vivo significance, particularly in the context of disease. We note that the loss in N-fragment immunostaining intensity in the INF2 R218Q mutant kidney is not limited to foot process structures. A grossly reduced staining intensity of this fragment is also noted in the cell body. By contrast, the staining intensity of the INF2 C-fragment 
MATERIALS AND METHODS
Cell culture
Mouse podocytes generated from wild-type and INF2 KO C57BL/6 mice (Supplementary Figure 3) and human podocytes (43) 
INF2 isoform analysis
Total RNA of human podocytes was extracted per manufacturer's instructions (Qiagen, Germantown, MD) and 1 μg RNA was used for cDNA synthesis (Transcriptor first strand cDNA synthesis kit, Roche). INF2 was then PCR amplified from cDNA using isoform-specific primers (Supplementary Figure 1) (Accuprime DNA Polymerase system, ThermoFisher). The PCR amplified product was gelpurified and examined for INF2-isoform-specific sequences using DNA sequencing (Genewiz).
Cleavage site mapping and in silico INF2 cleavage analysis
HEK 293T cells were transiently transfected with the GFP-INF2-FLAG constructs using Lipofectamine 2000 (Invitrogen). After incubation for 24 hr, the cells were lysed in RIPA buffer and the clarified supernatant was subjected to immunoprecipitation by anti-flag M2 beads (Sigma) for 2 hr, followed by washing and elution by anti-flag peptide (Sigma). The eluates were run on a 4-20% denaturing gel, transferred to a PVDF membrane, and stained using Coomassie blue. The C-fragment band was cut, digested per vendor guidelines (Alphalyse, Palo Alto, CA) and subjected to N-terminal sequencing. To assess the cleavage sites in INF2 in silico, we used the PROSPER bioinformatics tool.
In vitro cleavage assay
The in vitro cleavage assay was performed as described previously (39) . 
Immunofluorescence
Cells were stained and imaged using confocal microscopy as described previously (30) . Briefly, cells were fixed with 4% paraformaldehyde for 15 min, PBS-rinsed, and permeabilized 15 min with 0.5% Triton x-100. The fixed cells were then blocked with 5% BSA followed by sequential incubation with primary and secondary antibodies in blocking buffer. Following antibody incubations, cell nuclei were counterstained with Hoechst (dsDNA) (Invitrogen), mounted using ProLong Diamond Antifade (Invitrogen), and imaged by confocal microscopy (Zeiss LSM 510). All images were collected using ZEN lite 2.3 (black edition) and processed using ZEN lite 2.3 (blue version).
Structured Illumination Microscopy (SIM) and Image analysis
SIM analysis of kidney biopsy section samples was performed using a Zeiss Elyra SP.1 system, as described previously (44) . Briefly, z-stacks were acquired over a volume of 75.44 x 75.44 x 4 μm 3 (length x width x depth) with a slice-to-slice distance of 0.13 micron. The 34 μm period grating was shifted five times and rotated five times on every frame. SIM processing post-image acquisition was performed in 3D stacks using Zeiss ZEN software with default processing parameter settings.
The SIM-processed frames were then converted to a maximum intensity projection image using ZEN software or individually analyzed for foot process organization and INF2 localization using FIJI software. The foot processes were tracked in z-stack frames by synaptopodin staining. Foot process regions at points orthogonal to the imaging frame were defined as "Regions Of Interest" (ROI) and used for analysis. The profiles of synaptopodin and INF2 fluorescence intensity were then plotted and examined for co-localization of peaks.
INF2 knockout mouse
A neomycin cassette was introduced into the mouse Inf2 gene locus by homologous recombination to generate an Inf2 knockout allele in C57Bl/6 embryonic stem cells. The cassette targets the Inf2 gene locus spanning the start site of Inf2 transcription, causing a complete loss of INF2 expression.
Correctly targeted embryonic stem cells were injected into 8-cell Swiss Webster mouse embryos.
Embryos were cultured overnight and transferred into pseudo pregnant female mice 2.5 days postcoitus. F0 male mice were bred with C57BL/6 mice to generate KO mice (See Supplementary Figure   3 ). All mice were used for experiments after breeding for at least five generations.
Statistical analysis
All statistical analyses were performed using one-way analysis of variance between test-groups.
When statistical significance was seen, Turkey's multiple comparison test was used to find group differences. Statistical significance was set at a minimal value of p <0.05. All calculations were made using GraphPad Prism Version 7, and all values were reported as means ± standard deviation.
Human kidney studies
Human kidney biopsy material was obtained from Beth Israel Deaconess Medical Center (BIDMC) or outside institutions in accordance with a protocol approved by the Institutional Review Board at BIDMC. 
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